Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies.

Smoldering multiple myeloma (SMM) represents a heterogeneous precursor stage between monoclonal gammopathy of undetermined significance and symptomatic multiple myeloma (MM). Advances in diagnostic criteria, particularly the adoption of the SLiM-CRAB…

Preview only. Read the full abstract at the source